Continuous intravenous versus intermittent bolus midazolam with remifentanil during arteriovenous fistula placement with monitored anesthesia care in chronic renal failure patients: a randomized controlled trial

BACKGROUND: There is limited data on the use of intravenous continuous infusion (CI) versus intravenous intermittent bolus (IB) doses of midazolam for conscious sedation in patients with chronic renal failure. Unexpected adverse events can occur in chronic renal failure patients undergoing short pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagiroglu, Gonul, Baysal, Ayse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270617/
https://www.ncbi.nlm.nih.gov/pubmed/32493052
http://dx.doi.org/10.5144/0256-4947.2020.175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270617/
https://www.ncbi.nlm.nih.gov/pubmed/32493052
http://dx.doi.org/10.5144/0256-4947.2020.175

Ejemplares similares